← Back to Search

Virtual Reality Gait Training for Amputee Rehabilitation (VRVO2 Trial)

N/A

Waitlist Available

Led By Jason M Wilken, PT, PhD

Research Sponsored by Brooke Army Medical Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Trans-femoral participants must use an ischial containment socket

Ability to ambulate continuously for a minimum of 15 minutes

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 3 weeks later from first post training testing

Awards & highlights

VRVO2 Trial Summary

This trial is looking at whether an innovative new gait training program can help people with a traumatic lower extremity amputation improve their physiological and functional gait performance.

Who is the study for?

This trial is for individuals with a single lower limb amputation due to trauma, who can walk on their own for at least 15 minutes and have mild or no pain. They must have good muscle strength in the non-amputated leg and use a specific type of prosthetic socket if they've had an above-knee amputation.Check my eligibility

What is being tested?

The study tests a new gait training program using virtual reality and real-time feedback to improve walking performance in people with traumatic lower extremity amputations. It aims to see how this training affects walking mechanics and energy use.See study design

What are the potential side effects?

Since this is a physical therapy intervention involving gait training, potential side effects may include muscle soreness, fatigue, or discomfort during exercise. The risk of falls could also be present due to challenges in balance while adapting to the training.

VRVO2 Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I use an ischial containment socket for my prosthetic leg.

Select...

I can walk non-stop for at least 15 minutes.

Select...

My unaffected leg's ankle, knee, and hip are strong.

Select...

I have had one leg amputated below the knee or above the knee due to injury.

Select...

I have been walking on my own without help for at least three months.

VRVO2 Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 3 weeks later from first post training testing

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~3 weeks later from first post training testing

This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 weeks later from first post training testing for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Gait Oxygen Consumption

VRVO2 Trial Design

1Treatment groups

Experimental Treatment

Group I: Gait TrainingExperimental Treatment1 Intervention

0 / 5Eligibility criteria met

Find a Location

Who is running the clinical trial?

Brooke Army Medical CenterLead Sponsor

119 Previous Clinical Trials

26,493 Total Patients Enrolled

Jason M Wilken, PT, PhDPrincipal InvestigatorDirector, Military Performance Lab-Center for the Intrepid

11 Previous Clinical Trials

282 Total Patients Enrolled

Media Library

Gait Training Clinical Trial Eligibility Overview. Trial Name: NCT01225432 — N/A

Metabolic Syndrome Research Study Groups: Gait Training

Metabolic Syndrome Clinical Trial 2023: Gait Training Highlights & Side Effects. Trial Name: NCT01225432 — N/A

Gait Training 2023 Treatment Timeline for Medical Study. Trial Name: NCT01225432 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there still open slots for participants in this experiment?

"This clinical trial, initially posted on August 1st 2007 and last updated October 20th 2010, is not presently looking for patients. However, there are still other open trials that need to recruit participants."

Answered by AI

Is it feasible to join this clinical trial?

"This research requires 66 volunteers, aged between 18 and 45 with raised metabolic cost. Furthermore, in order to qualify for the trial they must have had a unilateral traumatic amputation of either their tibia or femur; demonstrate independent ambulation without any aid for at least 3 months; be able walk continuously for 15 minutes; use an ischial containment socket if applicable; report VAS Pain scores lower than 4/10 on the affected side and a sagittal plane ankle, knee and hip strength rating of 4 or better on the unaffected limb as confirmed by manual muscle testing."

Answered by AI